Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,944
The Omeza Protocol for Chronic Ulcers
for
Venous Leg Ulcer, Diabetic Foot Ulcer
Location: Dallas TX, Jacksonville FL, Newark NJ, Portland OR
Sponsor: Omeza, LLC
Sex: All
Age: 21 - 70+
Code: NCT04198441
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
for
Prostate Cancer
Location: Dallas TX, San Antonio TX, Metairie LA, Kansas City KS,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06780670
Phase 2, Phase 3, Recruiting
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
for
Non-Small-Cell Lung Cancer,
Location: Dallas TX, Houston TX, Aurora CO, Arlington Heights IL,
Sponsor: ArriVent BioPharma, Inc.
Sex: All
Age: 18+
Code: NCT07185997
Phase 3, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: Dallas TX, St Louis MO, Indianapolis IN, Rochester MN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)
for
Pancreatic Adenocarcinoma
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04926467
Phase 2, Recruiting
Analysis of Graft Function Following Autologous Islet Transplantation
for
Chronic Pancreatitis
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT03097185
Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Dallas TX, Tyler TX, Shreveport LA, San Antonio TX,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Dallas TX, Nashville TN, Denver CO, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Dallas TX, Round Rock TX, Austin TX, Hot Springs AR,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
Shield Post-Approval Study Protocol
for
Colo-rectal Cancer
Location: Garland TX, Paris TX, Shenandoah TX, Tomball TX,
Sponsor: Guardant Health, Inc.
Sex: All
Age: 45 - 70+
Code: NCT06880055
Recruiting
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
for
Non-Small Cell Lung Cancer
Location: Dallas TX, San Antonio TX, Beaumont TX, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07680790
Phase 3, Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Dallas TX, Plano TX, Austin TX, Houston TX,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07052903
Phase 3, Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: Dallas TX, Tyler TX, Little Rock AR, Lincoln NE,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase 2, Recruiting
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
for
Lung Cancer
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT03563976
Recruiting
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Dallas TX, Denton TX, Oklahoma City OK, Houston TX,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07039916
Phase 3, Recruiting
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
for
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC),